Aristide Merola
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Botulinum Toxin and Related Neurological Disorders, Genetic Neurodegenerative Diseases, Cardiovascular Syncope and Autonomic Disorders
Most-Cited Works
- → Technology in Parkinson's disease: Challenges and opportunities(2016)646 cited
- → Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts(2018)329 cited
- → A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies(2019)323 cited
- → Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter(2009)271 cited
- → Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases(2019)262 cited
- → Altered Glutamate Reuptake in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Cortex: Correlation With Microglia Infiltration, Demyelination, and Neuronal and Synaptic Damage(2007)205 cited